- Significant changes within politics paint a promising picture for the cannabinoid industry
- MCOA is involved in the cultivation, manufacture and distribution of hemp-derived products
- MCOA recently announced the launch of its reformulated, patent pending product, hempSMART™ Brain
President Trump recently made the statement that he is likely to back the States Act introduced by Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA), which removes federal involvement into state-by-state medical and recreational cannabis legislation. This is great news for those in the U.S. cannabinoid market (http://ibn.fm/Zq54b). Also, significant changes have taken place in the political acceptance of the cultivation of hemp on American soil. In a bipartisan move, Senator Chuck Schumer (D-NY) announced last month he will be signing Senator Mitch McConnell’s (R-KY) Industrial Hemp Farming Act of 2018. The bill seeks to remove industrial hemp from the same definition of marijuana under the Controlled Substances Act. Schumer referred to the current federal law as a crock, stating, “It makes no sense that the DEA is the primary regulator, and that they stop farmers and investors from growing hemp. Why are we buying hemp from other countries, when we have hundreds of acres that could be grown right here in our backyard?” (http://ibn.fm/YI66f).
Marijuana Company of America, Inc. (OTC: MCOA) operates as an umbrella company supporting a variety of portfolio businesses that participate within the legal cannabis and hemp industry by providing turnkey products and services. First and foremost an industrial hemp company, the majority of MCOA’s offerings relate to the cultivation and distribution of hemp-derived products.
MCOA announced on June 5, 2018, its hempSMART™ brand relaunched its flagship patent pending product, hempSMART™ Brain. In a news release, Donald Steinberg, CEO of MCOA, stated, “After reviewing our hempSMART Brain product, our formulators chose to improve upon the original product by doubling the original dosage of CBD. Our team is proud to be able to welcome our flagship product back onto the market and look forward to the upcoming marketing campaigns.”
The improved formulation includes 300mg per bottle of full spectrum, non-psychoactive, water soluble CBD (10mg per serving), along with a botanical blend of all-natural plant-based ingredients. To learn more about the hempSMART™ Brain product, read the full press release (http://ibn.fm/xZENn). The brand offers a line of CBD products and the opportunity to distribute the products as part of an affiliate network marketing model.
For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com
Important Information
Marijuana Company of America, Inc. (“Company”) complies with Section 17(b) of the 1933 Securities and Exchange Act. The Company retained NetworkNewsWire to publish information about the Company. To comply with Section 17(b) of the Securities Act of 1933, the Company discloses that it retained and paid Network News Wire with a cash payment of $5,000 per month to publish news, updates, articles and content about the Company.
